NCT03399734View on ClinicalTrials.gov

Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

March 9, 2018

Study Completion Date

March 9, 2018

Conditions

Healthy Participants

Interventions

DRUG

Perampanel

Single oral dose of 1 x 4-mg perampanel tablet

DRUG

Perampanel

Single 4-mg dose of perampanel fine granules

Trial Locations (1)

Unknown

Eisai Trial Site, Toshima-ku

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT03399734 - Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter